NCT00240578View on ClinicalTrials.gov

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Lymphoma, Non-Hodgkin
Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY